•The new offices in Costa Rica will provide IT services for Eurofins’ operations in North and South America
•The company’s new site is in UltraPark and represents an investment of US$250.000
San José, Costa Rica June 13th 2018. Eurofins Scientific, a global leader in bio-analysis, inaugurated its new offices in Costa Rica and foresees hiring up to 50 Costa Ricans with knowledge in Information Technology, professionals related to IT infrastructure, Data Center and IT operations, as well to application development, architecture, design, and support.
Eurofins chose Costa Rica as the location to open its new site based on the country’s good reputation in terms of education, especially in the Information technology field, as well as for the good image of the IT services that big companies transferred to Costa Rica. Eurofins will also, over time, hire up to 50 Costa Rican engineers.
“We thank Eurofins the trust given to Costa Rica by opening this new center of technology. This government will continue to work for the investment climate and the quality of the human talent that make Costa Rica today an attractive place to invest; so it continues, as well, strengthening and adapting to the requirements of the world’s labor industry” affirmed the Minister of Communications, Juan Carlos Mendoza.
Stefan Heiden, Director IT Infrastructure and Operations – Global said “Excited to announce the inauguration and start-up of Eurofins here at Costa Rica. I am hopeful that we will be able to benefit from the country with its skillsets, workforce and business environment. Looking forward to establish the service center and glad that Costa Rica is a part of our global service center strategy”.
The Minister of Foreign Trade in office, Duayner Salas, commented: “Eurofins’ opening shows, once more, how Costa Rica has turned into
a strategic place for the operations of renown worldwide companies. The technology
center inaugurated today is a great input for the Costa Rican economy, specifically
in the services sector, which began with 6 companies in 2000 and today has more
than 157 operations, highly diversified and innovative. In this context, the government
of Costa Rica reaffirms its compromise to continue strengthening the competitive
conditions so more leader companies establish in the country. We thank Eurofins
for choosing Costa Rica and we look forward to grow together”.
Sajith Chakkingal, Offshore Director - IT Infrastructure & Operations of Eurofins, commented: “We are very happy to be able to announce the inauguration of our new IT support/services site in Costa Rica. This will be Eurofins’ third service delivery center, following one in Bangalore (India) and one in Penang (Malaysia). Our new site in Costa Rica will deliver offshore IT services for our operations in North and South America.”
Jorge Sequeira, Managing Director of CINDE, added: “Eurofins trusted Costa Rica and its human talent to expand their operations to provide quality IT services to the company’s global operations. In 2017 alone, Costa Rica IT and IT-related services exports represented 48% of the total country’s services exports and we expect to increase this number with the help of well-recognized companies such as Eurofins.”
Those interested in applying for a job position in the company, can send their resume to the following email address: email@example.com or apply in www.eurofins.crAbout Eurofins
Eurofins – a global leader in bio-analysis
Eurofins Scientific through its subsidiaries (hereinafter sometimes “Eurofins” or “the Group”) believes it is a scientific leader in food, environment and pharmaceutical products testing and in agroscience CRO services. It is also one of the independent market leaders in certain testing and laboratory services for genomics, discovery pharmacology, forensics, CDMO, advanced material sciences and for supporting clinical studies. In addition, Eurofins is one of the emerging players in specialty clinical diagnostic testing in Europe and the USA. With over 35,000 staff in more than 400 laboratories across 44 countries, Eurofins offers a portfolio of over 150,000 analytical methods for evaluating the safety, identity, composition, authenticity, origin, and purity of biological substances and products, as well as for innovative clinical diagnostic. The Group objective is to provide its customers with high-quality services, accurate results on time and expert advice by its highly qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.
As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients’ increasingly stringent quality and safety standards and the expanding demands of regulatory authorities around the world.
For further press information